Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Dragonfly Therapeutics
Filamon LTD
Fondazione del Piemonte per l'Oncologia
Dana-Farber Cancer Institute
Hoffmann-La Roche
ViroMissile, Inc.
Bristol-Myers Squibb
Dana-Farber Cancer Institute
Kaiser Permanente
Children's Oncology Group
AstraZeneca
Pfizer
Arvinas Inc.
Immatics US, Inc.
Tizona Therapeutics, Inc
BioInvent International AB
Essen Biotech
Essen Biotech
DualityBio Inc.
MacroGenics
xCures
Daiichi Sankyo
University of Nebraska
National Institutes of Health Clinical Center (CC)
Second Life Therapeutics
Ocellaris Pharma, Inc.
Fusion Pharmaceuticals Inc.
Innate Pharma
Novartis
M.D. Anderson Cancer Center
Mayo Clinic
University Health Network, Toronto
NeoTX Therapeutics Ltd.
Cancer Research UK
TScan Therapeutics, Inc.
Bolt Biotherapeutics, Inc.
Memorial Sloan Kettering Cancer Center
Actym Therapeutics, Inc.
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
Hadassah Medical Organization
Pfizer
Travera Inc
Washington University School of Medicine
Incyte Corporation
Palleon Pharmaceuticals, Inc.